Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
Work
Year: 2016
Type: article
Abstract: Daratumumab, a human IgGκ monoclonal antibody that targets CD38, induces direct and indirect antimyeloma activity and has shown substantial efficacy as monotherapy in heavily pretreated patients with ... more
Source: New England Journal of Medicine
Institutions University of Turin, Mayo Clinic in Florida, WinnMed, Jacksonville College, Universitätsklinikum Tübingen +16 more
Cites: 37
Cited by: 1,372
Related to: 10
FWCI: 113.7
Citation percentile (by year/subfield): 99.99
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze